Pacer Advisors Portfolio holdings
AUM
$39.6B
This Quarter Return
-4.31%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$43.7B
AUM Growth
+$43.7B
(+0.36%)
Cap. Flow
+$2.97B
Cap. Flow
% of AUM
6.8%
Top 10 Holdings %
Top 10 Hldgs %
11.64%
Holding
4,109
New
199
Increased
900
Reduced
1,255
Closed
190
Top Buys
| 1 |
Hewlett Packard
HPE
|
$488M |
| 2 |
Halliburton
HAL
|
$458M |
| 3 |
Archer Daniels Midland
ADM
|
$456M |
| 4 |
Gen Digital
GEN
|
$413M |
| 5 |
WESCO International
WCC
|
$251M |
Top Sells
| 1 |
Vistra
VST
|
$614M |
| 2 |
Exxon Mobil
XOM
|
$498M |
| 3 |
Chevron
CVX
|
$435M |
| 4 |
Occidental Petroleum
OXY
|
$432M |
| 5 |
Cisco
CSCO
|
$411M |
Sector Composition
| 1 | Consumer Discretionary | 17.28% |
| 2 | Technology | 17.14% |
| 3 | Energy | 14.05% |
| 4 | Industrials | 10.98% |
| 5 | Healthcare | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Anavex Life Sciences
AVXL
$817M
| $5.39K | ﹤0.01% |
1,276
-1,844
| -59% | -$7.78K |
|
1402
Full Truck Alliance
YMM
$13.8B
| $5.23K | ﹤0.01% |
651
-45
| -6% | -$362 |
|
1403
Heron Therapeutics
HRTX
$204M
| $5.13K | ﹤0.01% |
+1,465
| New | +$5.13K |
|
1404
C4 Therapeutics
CCCC
$182M
| $4.88K | ﹤0.01% |
1,056
-2,873
| -73% | -$13.3K |
|
1405
Fate Therapeutics
FATE
$115M
| $4.68K | ﹤0.01% |
1,426
-1,968
| -58% | -$6.46K |
|
1406
Oric Pharmaceuticals
ORIC
$1.03B
| $4.67K | ﹤0.01% |
661
+145
| +28% | +$1.03K |
|
1407
Cabaletta Bio
CABA
$144M
| $4.41K | ﹤0.01% |
589
-1,064
| -64% | -$7.96K |
|
|
VERV
1408
DELISTED
Verve Therapeutics
VERV
| $4.14K | ﹤0.01% |
849
-1,164
| -58% | -$5.68K |
|
1409
ARS Pharmaceuticals
SPRY
$1.08B
| $4.13K | ﹤0.01% |
485
-31
| -6% | -$264 |
|
1410
Voyager Therapeutics
VYGR
$204M
| $4.02K | ﹤0.01% |
508
-46
| -8% | -$364 |
|
1411
Zentalis Pharmaceuticals
ZNTL
$123M
| $3.9K | ﹤0.01% |
953
-433
| -31% | -$1.77K |
|
|
CRGX
1412
DELISTED
CARGO Therapeutics
CRGX
| $3.78K | ﹤0.01% |
230
+5
| +2% | +$82 |
|
1413
Tango Therapeutics
TNGX
$745M
| $3.56K | ﹤0.01% |
415
-607
| -59% | -$5.21K |
|
|
MTLS
1414
Materialise
MTLS
$291M
| $3.2K | ﹤0.01% |
639
-451
| -41% | -$2.26K |
|
1415
Savara
SVRA
$591M
| $3.11K | ﹤0.01% |
+771
| New | +$3.11K |
|
|
ITOS
1416
DELISTED
iTeos Therapeutics
ITOS
| $3.04K | ﹤0.01% |
+205
| New | +$3.04K |
|
1417
Matsons
MATX
$3.24B
| $3.01K | ﹤0.01% |
23
-4
| -15% | -$524 |
|
1418
Energizer
ENR
$1.94B
| $2.9K | ﹤0.01% |
98
-1,130
| -92% | -$33.4K |
|
1419
Fortrea Holdings
FTRE
$971M
| $2.85K | ﹤0.01% |
122
+17
| +16% | +$397 |
|
1420
Humacyte
HUMA
$231M
| $2.85K | ﹤0.01% |
+593
| New | +$2.85K |
|
1421
Nova
NVMI
$7.08B
| $2.81K | ﹤0.01% |
12
-266
| -96% | -$62.4K |
|
1422
Stepan Co
SCL
$1.09B
| $2.6K | ﹤0.01% |
31
+4
| +15% | +$336 |
|
1423
Alector
ALEC
$282M
| $2.6K | ﹤0.01% |
572
-716
| -56% | -$3.25K |
|
1424
Sanmina
SANM
$6.21B
| $2.52K | ﹤0.01% |
38
-3
| -7% | -$199 |
|
1425
Camtek
CAMT
$3.51B
| $2.51K | ﹤0.01% |
+20
| New | +$2.51K |
|